FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898849633> ?p ?o ?g. }

• W2898849633 endingPage "e000443" @default.
• W2898849633 startingPage "e000443" @default.
• W2898849633 abstract "Ramucirumab (RAM), a monoclonal antibody for vascular endothelial growth factor 2 (VEGFR2), has been effective for advanced gastric adenocarcinoma (AC). However, little is known about the efficacy of RAM-containing chemotherapy (RAM-CTx) in gastric neuroendocrine carcinoma (G-NEC).We retrospectively analysed and compared the clinical outcomes of patients (pts) with G-NEC receiving RAM-CTx, G-NEC receiving CTx without RAM and AC receiving RAM-CTx in our hospital. G-NEC was defined by neuroendocrine carcinoma features, regardless of the proportion, based on histology and neuroendocrine markers (synaptophysin, chromogranin A or CD56). VEGFR2 expression in tumour vessels was evaluated in archival primary G-NEC tissues by immunohistochemistry using the same anti-VEGFR2 primary antibody and scoring scheme (vascular VEGFR2 H-score) as in the REGARD trial.Seventeen G-NEC receiving RAM-CTx, 13 G-NEC receiving CTx without RAM and 173 AC pts receiving RAM-CTx were analysed. The overall response rate (59% vs 8 % vs 28%), progression-free survival (median 7.7 vs 1.8 vs 3.3 months) and overall survival (median 16.1 vs 8.6 vs 9.6 months) were significantly better in pts with G-NEC receiving RAM-CTx than G-NEC receiving CTx without RAM or AC receiving RAM-CTx. No severe or unexpected adverse events occurred. The median vascular VEGFR2 H-score, based on available G-NEC tissues from 12 pts receiving RAM-CTx, was 220 (range 150-260), which was markedly higher than that reported on AC tissues from the REGARD trial as historical control (median 35, range 0-240).RAM-CTx showed a promising activity without severe or unexpected safety profile in pts with G-NEC. This may in part be explained by higher vascular VEGFR2 expression in G-NEC tissues." @default.
• W2898849633 created "2018-11-09" @default.
• W2898849633 creator A5001115937 @default.
• W2898849633 creator A5003229513 @default.
• W2898849633 creator A5007326037 @default.
• W2898849633 creator A5015799240 @default.
• W2898849633 creator A5024904484 @default.
• W2898849633 creator A5032930623 @default.
• W2898849633 creator A5043738572 @default.
• W2898849633 creator A5044642565 @default.
• W2898849633 creator A5046439279 @default.
• W2898849633 creator A5060366426 @default.
• W2898849633 creator A5062037909 @default.
• W2898849633 creator A5062748030 @default.
• W2898849633 creator A5063648563 @default.
• W2898849633 creator A5082685387 @default.
• W2898849633 date "2018-01-01" @default.
• W2898849633 modified "2023-09-25" @default.
• W2898849633 title "Efficacy and safety of ramucirumab-containing chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma" @default.
• W2898849633 cites W1506180242 @default.
• W2898849633 cites W1569087857 @default.
• W2898849633 cites W1967988142 @default.
• W2898849633 cites W1977067741 @default.
• W2898849633 cites W1985359220 @default.
• W2898849633 cites W2027170387 @default.
• W2898849633 cites W2039777524 @default.
• W2898849633 cites W2041644816 @default.
• W2898849633 cites W2082146700 @default.
• W2898849633 cites W2093975374 @default.
• W2898849633 cites W2104759721 @default.
• W2898849633 cites W2111237964 @default.
• W2898849633 cites W2158474413 @default.
• W2898849633 cites W2161676563 @default.
• W2898849633 cites W2326581607 @default.
• W2898849633 cites W2519828822 @default.
• W2898849633 cites W2586697182 @default.
• W2898849633 doi "https://doi.org/10.1136/esmoopen-2018-000443" @default.
• W2898849633 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6212678" @default.
• W2898849633 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30425849" @default.
• W2898849633 hasPublicationYear "2018" @default.
• W2898849633 type Work @default.
• W2898849633 sameAs 2898849633 @default.
• W2898849633 citedByCount "9" @default.
• W2898849633 countsByYear W28988496332019 @default.
• W2898849633 countsByYear W28988496332020 @default.
• W2898849633 countsByYear W28988496332021 @default.
• W2898849633 countsByYear W28988496332022 @default.
• W2898849633 countsByYear W28988496332023 @default.
• W2898849633 crossrefType "journal-article" @default.
• W2898849633 hasAuthorship W2898849633A5001115937 @default.
• W2898849633 hasAuthorship W2898849633A5003229513 @default.
• W2898849633 hasAuthorship W2898849633A5007326037 @default.
• W2898849633 hasAuthorship W2898849633A5015799240 @default.
• W2898849633 hasAuthorship W2898849633A5024904484 @default.
• W2898849633 hasAuthorship W2898849633A5032930623 @default.
• W2898849633 hasAuthorship W2898849633A5043738572 @default.
• W2898849633 hasAuthorship W2898849633A5044642565 @default.
• W2898849633 hasAuthorship W2898849633A5046439279 @default.
• W2898849633 hasAuthorship W2898849633A5060366426 @default.
• W2898849633 hasAuthorship W2898849633A5062037909 @default.
• W2898849633 hasAuthorship W2898849633A5062748030 @default.
• W2898849633 hasAuthorship W2898849633A5063648563 @default.
• W2898849633 hasAuthorship W2898849633A5082685387 @default.
• W2898849633 hasBestOaLocation W28988496331 @default.
• W2898849633 hasConcept C126322002 @default.
• W2898849633 hasConcept C143998085 @default.
• W2898849633 hasConcept C204232928 @default.
• W2898849633 hasConcept C2776694085 @default.
• W2898849633 hasConcept C2777209535 @default.
• W2898849633 hasConcept C2779551604 @default.
• W2898849633 hasConcept C71924100 @default.
• W2898849633 hasConcept C77231918 @default.
• W2898849633 hasConcept C90924648 @default.
• W2898849633 hasConceptScore W2898849633C126322002 @default.
• W2898849633 hasConceptScore W2898849633C143998085 @default.
• W2898849633 hasConceptScore W2898849633C204232928 @default.
• W2898849633 hasConceptScore W2898849633C2776694085 @default.
• W2898849633 hasConceptScore W2898849633C2777209535 @default.
• W2898849633 hasConceptScore W2898849633C2779551604 @default.
• W2898849633 hasConceptScore W2898849633C71924100 @default.
• W2898849633 hasConceptScore W2898849633C77231918 @default.
• W2898849633 hasConceptScore W2898849633C90924648 @default.
• W2898849633 hasIssue "7" @default.
• W2898849633 hasLocation W28988496331 @default.
• W2898849633 hasLocation W28988496332 @default.
• W2898849633 hasLocation W28988496333 @default.
• W2898849633 hasLocation W28988496334 @default.
• W2898849633 hasOpenAccess W2898849633 @default.
• W2898849633 hasPrimaryLocation W28988496331 @default.
• W2898849633 hasRelatedWork W1987151058 @default.
• W2898849633 hasRelatedWork W1992859936 @default.
• W2898849633 hasRelatedWork W1998447009 @default.
• W2898849633 hasRelatedWork W2077488880 @default.
• W2898849633 hasRelatedWork W2411603119 @default.
• W2898849633 hasRelatedWork W2469112183 @default.
• W2898849633 hasRelatedWork W2530808602 @default.
• W2898849633 hasRelatedWork W2611001627 @default.
• W2898849633 hasRelatedWork W3005960716 @default.

• next